| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Da Prada M, Pieri L, Kell... |
Effects of 5,6-Dihydroxytryptamine and 5,7-Dihydroxytryptamine on the ... |
Ann.N.Y.Acad.Sci. |
1978 |
| Takeuchi Y, Ono Y, Hisana... |
A comparative study on the neurotoxicity of n-pentane, n-hexane, and n... |
Br J Ind Med |
1980 |
| Cheng AC, Castagnoli N |
Synthesis and physicochemical and neurotoxicity studies of 1-4-substit... |
J Med Chem |
1984 |
| Gandolfi O, Cheney DL, Ho... |
On the Neurotoxicity of Chlordecone: A Role for y-Aminobutyric Acid an... |
Brain Research |
1984 |
| Ricaurte G, Bryan G, Stra... |
Hallucinogenic amphetamine selectively destroys brain serotonin nerve ... |
Science |
1985 |
| Gehlert DR, Schmidt CJ, W... |
Evidence for specific methylenedioxymethamphetamine (ecstasy) binding ... |
Eur J Pharmacol |
1985 |
| Spencer PS, Schaumburg HH |
Organic solvent neurotoxicityFacts and research needs |
Scand J Work Environ... |
1985 |
| Beck J, Morgan PA |
Designer drug confusion: a focus on MDMA |
J Drug Educ |
1986 |
| Schmidt CJ |
Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphet... |
J Pharmacol Exp Ther |
1987 |
| Stone DM, Hanson GR, Gibb... |
Differences in the central serotonergic effects of methylenedioxymetha... |
Neuropharmacology |
1987 |
| Battaglia G, Yeh SY, de S... |
MDMA-induced neurotoxicity: parameters of degeneration and recovery of... |
Pharmacol Biochem Be... |
1988 |
| Logan BJ, Laverty R, Sand... |
Differences between rats and mice in MDMA (methylenedioxymethylampheta... |
Eur J Pharmacol |
1988 |
| O'Hearn E, Battaglia G, D... |
Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDM... |
J Neurosci |
1988 |
| Slikker W Jr, Ali SF, Sca... |
Neurochemical and neurohistological alterations in the rat and monkey ... |
Toxicol Appl Pharmac... |
1988 |
| Stone DM, Johnson M, Hans... |
Role of endogenous dopamine in the central serotonergic deficits induc... |
J Pharmacol Exp Ther |
1988 |
| Hekmatpanah CR, McKenna D... |
Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced n... |
Neurosci Lett |
1989 |
| Johnson M, Stone DM, Bush... |
Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... |
Eur J Pharmacol |
1989 |
| Johnson MP, Nichols DE |
Neurotoxic effects of the alpha-ethyl homologue of MDMA following suba... |
Pharmacol Biochem Be... |
1989 |
| Kleven MS, Woolverton WL,... |
Evidence that both intragastric and subcutaneous administration of met... |
Brain Res |
1989 |
| Lim HK, Foltz RL |
Identification of metabolites of 3,4-(methylenedioxy)methamphetamine i... |
Chem Res Toxicol |
1989 |
| Peroutka SJ |
'Ecstasy': a human neurotoxin? |
Arch Gen Psychiatry |
1989 |
| Ricaurte GA |
Studies of MDMA-induced neurotoxicity in nonhuman primates: a basis fo... |
NIDA Res Monogr |
1989 |
| Seiden LS, Kleven MS |
Methamphetamine and related drugs: toxicity and resulting behavioral c... |
NIDA Res Monogr |
1989 |
| Stone DM, Hanson GR, Gibb... |
In vitro reactivation of rat cortical tryptophan hydroxylase following... |
J Neurochem |
1989 |
| Gibb JW, Stone DM, Johnso... |
Role of dopamine in the neurotoxicity induced by amphetamines and rela... |
NIDA Res Monogr |
1989 |
| De Souza EB, Battaglia G,... |
Neurotoxic effect of MDMA on brain serotonin neurons: evidence from ne... |
Ann N Y Acad Sci |
1990 |
| Finnegan KT, Skratt JJ, I... |
The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prev... |
Neurosci Lett |
1990 |
| Gibb JW, Johnson M, Hanso... |
Neurochemical basis of neurotoxicity |
Neurotoxicology |
1990 |
| Grob C, Bravo G, Walsh R |
Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxic... |
Arch Gen Psychiatry |
1990 |
| Johnson MP, Huang XM, Obe... |
Behavioral, biochemical and neurotoxicological actions of the alpha-et... |
Eur J Pharmacol |
1990 |
| McKenna DJ, Peroutka SJ |
Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine ... |
J Neurochem |
1990 |
| Molliver ME, Berger UV, M... |
Neurotoxicity of MDMA and related compounds: anatomic studies |
Ann N Y Acad Sci |
1990 |
| Nichols DE, Brewster WK, ... |
Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amph... |
J Med Chem |
1990 |
| Scheffel U, Ricaurte GA |
Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamin... |
Brain Res |
1990 |
| Schmidt CJ, Abbate GM, Bl... |
Selective 5-hydroxytryptamine2 receptor antagonists protect against th... |
J Pharmacol Exp Ther |
1990 |
| Schmidt CJ, Black CK, Abb... |
Chloral hydrate anesthesia antagonizes the neurotoxicity of 3,4-methyl... |
Eur J Pharmacol |
1990 |
| Schmidt CJ, Black CK, Abb... |
Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity a... |
Brain Res |
1990 |
| Schmidt CJ, Black CK, Tay... |
Antagonism of the neurotoxicity due to a single administration of meth... |
Eur J Pharmacol |
1990 |
| Schmidt CJ, Kehne JH |
Neurotoxicity of MDMA: neurochemical effects |
Ann N Y Acad Sci |
1990 |
| McKenna DJ, Guan XM, Shul... |
3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... |
Pharmacol Biochem Be... |
1991 |
| Paris JM, Cunningham KA |
Lack of Neurotoxicity after Intra-Raphe Micro-Injections of MDMA ('Ecs... |
NIDA Res Monogr |
1991 |
| Johnson MP, Frescas SP, O... |
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... |
J Med Chem |
1991 |
| Ali SF, Chang LW, Slikker... |
Biogenic amines as biomarkers for neurotoxicity |
Biomed Environ Sci |
1991 |
| Champney TH, Matthews RT |
Pineal serotonin is resistant to depletion by serotonergic neurotoxins... |
J Pineal Res |
1991 |
| Huang XM, Johnson MP, Nic... |
Reduction in brain serotonin markers by alpha-ethyltryptamine (Monase) |
Eur J Pharmacol |
1991 |
| Johnson MP, Frescas SP, O... |
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... |
J Med Chem |
1991 |
| Johnson MP, Huang XM, Nic... |
Serotonin neurotoxicity in rats after combined treatment with a dopami... |
Pharmacol Biochem Be... |
1991 |
| Nash JF, Nichols DE |
Microdialysis studies on 3,4-methylenedioxyamphetamine and structurall... |
Eur J Pharmacol |
1991 |
| Nichols DE, Johnson MP, O... |
5-Iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine |
Pharmacol Biochem Be... |
1991 |
| Schechter MD |
Effect of MDMA neurotoxicity upon its conditioned place preference and... |
Pharmacol Biochem Be... |
1991 |
| Schmidt CJ, Taylor VL, Ab... |
5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-m... |
J Pharmacol Exp Ther |
1991 |
| Steele TD, Brewster WK, J... |
Assessment of the role of alpha-methylepinine in the neurotoxicity of ... |
Pharmacol Biochem Be... |
1991 |
| Olney JW, Labruyere J, Wa... |
NMDA antagonist neurotoxicity: mechanism and prevention |
Science |
1991 |
| Grob CS, Bravo GL, Walsh ... |
The MDMA-neurotoxicity controversy: implications for clinical research... |
J Nerv Ment Dis |
1992 |
| Hashimoto K, Maeda H, Gor... |
Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-me... |
Brain Res |
1992 |
| Hashimoto K, Maeda H, Gor... |
Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity ... |
Eur J Pharmacol |
1992 |
| Huang X, Marona-Lewicka D... |
p-Methylthioamphetamine is a Potent New Non-Neurotoxic Serotonin-Relea... |
Eur J Pharmacol |
1992 |
| Kosten TR, Price LH |
Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use [C... |
Journal of Nervous &... |
1992 |
| Nash JF, Yamamoto BK |
Methamphetamine neurotoxicity and striatal glutamate release: comparis... |
Brain Res |
1992 |
| Paris JM, Cunningham KA |
Lack of serotonin neurotoxicity after intraraphe microinjection of (+)... |
Brain Res Bull |
1992 |
| Ricaurte GA, McCann UD |
Neurotoxic amphetamine analogues: effects in monkeys and implications ... |
Ann N Y Acad Sci |
1992 |
| Steele TD, Katz JL, Ricau... |
Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-amin... |
Brain Res |
1992 |
| Huang X, Marona-Lewicka D... |
p-methylthioamphetamine is a potent new non-neurotoxic serotonin-relea... |
Eur J Pharmacol |
1992 |
| Krogsgaard-Larsen P, Hans... |
Naturally-occurring excitatory amino acids as neurotoxins and leads in... |
Toxicol Lett |
1992 |
| Malinovsky JM, Lepage JY,... |
Is ketamine or its preservative responsible for neurotoxicity in the r... |
Anesthesiology |
1993 |
| Ali SF, Newport GD, Scall... |
Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produc... |
Neurotoxicol Teratol |
1993 |
| Allen RP, McCann UD, Rica... |
Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, '... |
Sleep |
1993 |
| Brodkin J, Malyala A, Nas... |
Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetami... |
Pharmacol Biochem Be... |
1993 |
| Colado MI, Murray TK, Gre... |
5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MD... |
Br J Pharmacol |
1993 |
| McCann UD, Ricaurte GA |
Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetam... |
J Clin Psychopharmac... |
1993 |
| Miller DB, O'Callaghan JP |
The interactions of MK-801 with the amphetamine analogues D-methamphet... |
Ann N Y Acad Sci |
1993 |
| O'Callaghan JP, Miller DB |
Quantification of reactive gliosis as an approach to neurotoxicity ass... |
NIDA Res Monogr |
1993 |
| Ricaurte GA, Markowska AL... |
3,4-Methylenedioxymethamphetamine, serotonin and memory [published err... |
J Pharmacol Exp Ther |
1993 |
| Robinson TE, Castaneda E,... |
Effects of cortical serotonin depletion induced by 3,4-methylenedioxym... |
Neuropsychopharmacol... |
1993 |
| Axt KJ, Mamounas LA, Moll... |
Structural Features of Amphetamine Neurotoxicity in the Brain. Ampheta... |
Academic Press San D... |
1994 |
| Colado MI, Green AR |
A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of ... |
Br J Pharmacol |
1994 |
| Gudelsky GA, Yamamoto BK,... |
Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine rel... |
Eur J Pharmacol |
1994 |
| McCann UD, Ridenour A, Sh... |
Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (... |
Neuropsychopharmacol... |
1994 |
| Miller DB, O'Callaghan JP |
Environment-, drug- and stress-induced alterations in body temperature... |
J Pharmacol Exp Ther |
1994 |
| O'Callaghan JP, Miller DB |
Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mou... |
J Pharmacol Exp Ther |
1994 |
| Sprague JE, Huang X, Kant... |
Attenuation of 3,4-methylenedioxymethamphetamine (MDMA) induced neurot... |
Life Sci |
1994 |
| Steele TD, McCann UD, Ric... |
3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): pharmacology and ... |
Addiction |
1994 |
| Broening HW, Bowyer JF, S... |
Age-dependent sensitivity of rats to the long-term effects of the sero... |
J Pharmacol Exp Ther |
1995 |
| Cadet JL, Ladenheim B, Hi... |
Superoxide radicals mediate the biochemical effects of methylenedioxym... |
Synapse |
1995 |
| Cerruti C, Sheng P, Laden... |
Involvement of oxidative and L-arginine-NO pathways in the neurotoxici... |
Clin Exp Pharmacol P... |
1995 |
| Colado MI, Williams JL, G... |
The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 me... |
Br J Pharmacol |
1995 |
| Hegadoren KM, Baker GB, C... |
Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (... |
J Pharmacol Toxicol ... |
1995 |
| Heller A, Won L, Heller B... |
Examination of developmental neurotoxicity by the use of tissue cultur... |
Clin Exp Pharmacol P... |
1995 |
| Kramer HK, Poblete JC, Az... |
3,4-Methylenedioxymethamphetamine ('Ecstasy') promotes the translocati... |
Brain Res |
1995 |
| McCann UD, Ricaurte GA |
On the neurotoxicity of MDMA and related amphetamine derivatives [lett... |
J Clin Psychopharmac... |
1995 |
| Miller DB, O'Callaghan JP |
The role of temperature, stress, and other factors in the neurotoxicit... |
Mol Neurobiol |
1995 |
| Slikker W Jr, Gaylor DW |
Biologically based dose-response model for neurotoxicity risk assessme... |
Ann N Y Acad Sci |
1995 |
| Sprague JE, Nichols DE |
The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-meth... |
J Pharmacol Exp Ther |
1995 |
| Sprague JE, Nichols DE |
Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the... |
Psychopharmacology (... |
1995 |
| Miller RT, Serrine SL, Mo... |
Metabolism of 5-(Glutathion-S-yl)-a-methyldopamine Following Intracere... |
Chem Res Toxicol |
1995 |
| Moore KA, Mozayani A, Fie... |
Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methy... |
Forensic Sci Int |
1996 |
| Miller RT, Lau SS, Monks ... |
Effects of intracerebroventricular administration of 5-(glutathion-S-y... |
Chem Res Toxicol |
1996 |
| Sabol KE, Lew R, Richards... |
Methylenedioxymethamphetamine-induced serotonin deficits are followed ... |
J Pharmacol Exp Ther |
1996 |
| Malberg JE, Sabol KE, Sei... |
Co-administration of MDMA with drugs that protect against MDMA neuroto... |
J Pharmacol Exp Ther |
1996 |
| Gartside SE, McQuade R, S... |
Effects of repeated administration of 3,4-methylenedioxymethamphetamin... |
J Pharmacol Exp Ther |
1996 |
